Lund, Sweden - Clinical Laserthermia Systems AB (publ) ("CLS" or the "Company") today publishes its interim report for January - September 2025.Highlights of the Third Quarter Interim ReportDuring the ...
First full post acquisition quarter builds momentum for 2026 (Dignitana has been part of the group since June 1. Figures in parentheses refer to the outcome for the corresponding period of the previou ...
TipRanks on MSN
EQL Pharma Gains Approval for Cystohipp in Germany
EQL Pharma AB ( ($SE:EQL) ) has provided an update. EQL Pharma AB has received marketing approval in Germany for its key product, methenamine ...
The board of Canada's Barrick Mining has raised the possibility of splitting the company into two separate entities, with one focused on North America and the other centered on Africa and Asia, four ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback